RxDoctor Payments Data

Manjoo Sharma

Internal Medicine · Hempstead, NYNPI 1003857251

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Edwards Lifesciences at 25.6% of the total. Reporting peaked in 2023 at $1,749 and has fallen 52.6% since, to $828 in 2025.

$3,861in general payments, 2019–2025

Across 32 payments — averaging $120.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$989
  • Amgen$849
  • Eli Lilly$760
  • Janssen Research & Development, LLC$620
  • Novartis$519
  • Astellas Pharma US Inc$40
  • plus $84 from 4 others
$5,626,028in research payments, 2019–2025

Across 591 payments — averaging $9519.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Braintree Laboratories, Inc.$1.5M
  • Modernatx, Inc.$936K
  • Merck$711K
  • Eli Lilly$460K
  • AstraZeneca$440K
  • Novartis$410K
  • plus $1.2M from 9 others

What the payments were for

  • Travel & lodging$2,12255%
  • Food & beverage$1,73945%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,861 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in Hempstead

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →